iPath Inverse S&P 500 VIX Short-Term Futures
IVOP
IVOP was delisted on the 23rd of March, 2018.
4 hedge funds and large institutions have $409K invested in iPath Inverse S&P 500 VIX Short-Term Futures in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
60% less capital invested
Capital invested by funds: $1.03M → $409K (-$621K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.71K |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$38 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$38 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$619K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $364K | +$5.71K | +150 | +2% |
|
2
UBS Group
Zurich,
Switzerland
| $45K | +$45.3K | +1,190 | New |
|
|
3
Barclays
London,
United Kingdom
| – | -$619K | -16,291 | Closed |
|
|
4
Parallax Volatility Advisers
San Francisco,
California
| – | +$38 | +1 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | +$38 | +1 | New |
|
IVOP Hedge Fund Activity: Q4 2014 in Review
4 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) for Q4 2014, worth a combined $409K — down 60% from $1.03M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IVOP positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $5.71K. The largest seller was Barclays, exiting entirely with an estimated $619K sold.
- 4 institutional investors held iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) as of Q4 2014, up from 3 in Q3 2014.
- Funds reported $409K of iPath Inverse S&P 500 VIX Short-Term Futures stock for Q4 2014, down 60% quarter-over-quarter.
- 3 funds opened new iPath Inverse S&P 500 VIX Short-Term Futures positions in Q4 2014 and 1 closed out, a net change of +2 holders.
- The largest iPath Inverse S&P 500 VIX Short-Term Futures buyer in Q4 2014 was Susquehanna International Group, an estimated $5.71K added.
- The largest iPath Inverse S&P 500 VIX Short-Term Futures seller in Q4 2014 was Barclays, an estimated $619K sold.
Based on aggregated 13F filings for Q4 2014.